Streetbeat News

LXRX

Lexicon Pharmaceuticals, Inc.

https://www.lexpharma.com

Industry

Biotechnology

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Open

1.30

Mkt cap

459M

Volume

2.9M

High

1.32

P/E Ratio

-1.63

52-wk high

3.73

Low

1.20

Div yield

N/A

52-wk low

0.92

Lexicon Pharmaceuticals reported Q2 losses of $(0.22) per share, missing the analyst consensus estimate of $(0.17) by 29.41%. This is a 37.5% decrease over losses from the same period last year. However, the company reported quarterly sales of $317.00K, beating the analyst consensus estimate of $70.00K by 352.86%, a 805.71% increase over sales from the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 04, 2023 | 2:33 pm

Several US stocks are trading lower in the pre-market session. Levi Strauss & Co. (LEVI) shares dipped 8.2% despite reporting upbeat Q2 earnings, as the company lowered its annual profit outlook. BioXcel Therapeutics (BTAI) shares fell 7.4% following the release of topline results for a Phase 3 trial of BXCL501 for Alzheimer's disease-related agitation. Senseonics Holdings (SENS) shares dropped 5.4% after reporting equity grants to employees. Varonis Systems (VRNS) shares declined 4.8%, Lexicon Pharmaceuticals (LXRX) shares fell 3.2%, and Riot Platforms (RIOT) shares slipped 2.5% after issuing production and operations updates.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 10:48 am

Insiders at TransCode Therapeutics, Lexicon Pharmaceuticals, and Global Clean Energy Holdings have recently made significant purchases of their respective companies' shares. TransCode Therapeutics published new data supporting the use of TTX-MC138 for metastatic breast cancer treatment, Lexicon Pharmaceuticals announced the pricing of a $125 million public offering and concurrent private placement, and Global Clean Energy signed a $30 million USDA climate-smart commodities grant for its camelina project.

Portfolio Pulse from Lisa Levin

June 23, 2023 | 11:08 am

Insiders at Lexicon Pharmaceuticals, Avalo Therapeutics, and PEDEVCO have recently made significant stock purchases. Lexicon announced a $125 million public offering and concurrent private placement, Avalo posted a narrower-than-expected quarterly loss, and PEDEVCO expanded into Wyoming D-J Basin Codell Play.

Portfolio Pulse from Lisa Levin

June 21, 2023 | 12:56 pm

Lexicon Pharmaceuticals will present clinical study results for LX9211, a non-opioid treatment for diabetic peripheral neuropathic pain, and INPEFA, a recently approved drug for heart failure, at the American Diabetes Association's 83rd Scientific Sessions.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 12:17 pm

THOR Industries shares rose 14.6% after reporting better-than-expected Q3 results and raising FY23 EPS guidance. Other stocks with significant movements include Recruiter.com Group, Hoth Therapeutics, Visionary Education Technology Holdings Group, and Zura Bio Limited.

Portfolio Pulse from Lisa Levin

June 06, 2023 | 5:05 pm

Insiders have been aggressively buying shares in Lexicon Pharmaceuticals, Heliogen, ImmunityBio, and Nanophase Technologies. This indicates their confidence in the companies' prospects and can be considered a factor for investors and traders interested in penny stocks.

Portfolio Pulse from Lisa Levin

June 06, 2023 | 1:22 pm

In Tuesday's pre-market session, several stocks recorded gains, including Zura Bio, GitLab, Lexicon Pharmaceuticals, Hello Group, Uniti Group, Sprinklr, Unity Software, SunCar Technology Group, and Dave & Buster's Entertainment.

Portfolio Pulse from Lisa Levin

June 06, 2023 | 11:03 am

U.S. stocks traded mixed on Monday, with several big stocks recording losses. Castle Biosciences, EPAM Systems, and Amyris were among the companies experiencing significant drops in share prices.

Portfolio Pulse from Lisa Levin

June 05, 2023 | 3:30 pm

Several big stocks are moving lower in Friday's pre-market session, including SentinelOne, Elastic, ChargePoint Holdings, Ginkgo Bioworks, Lexicon Pharmaceuticals, Dell Technologies, and Broadcom.

Portfolio Pulse from Lisa Levin

June 02, 2023 | 10:44 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.